The first generic product from the family of immunomodulators of signaling pathways of tumor angiogenesis.
Targeted (small molecule) drug from the group of modulators of signaling pathways of epidermal growth factor receptor
Oral nonsteroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.
A small molecule inhibitor of EGF-receptor of tyrosinkinase.
Proteasome inhibitor. Reversibly inhibits the activity of 26S proteasome.
An unique cytotoxic agent with alkylating and antimetabolite properties
It is targeted therapy drug – chimeric monoclonal antibody to the lymphocyte’s transmembrane antigen CD20
Lung surfactant intended for intratracheal administration
Monoclonal antibody that interferes with the HER2/neu receptor